Skip to main content
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Home
Home

Advanced Search

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses

New Research In

Physical Sciences

Featured Portals

  • Physics
  • Chemistry
  • Sustainability Science

Articles by Topic

  • Applied Mathematics
  • Applied Physical Sciences
  • Astronomy
  • Computer Sciences
  • Earth, Atmospheric, and Planetary Sciences
  • Engineering
  • Environmental Sciences
  • Mathematics
  • Statistics

Social Sciences

Featured Portals

  • Anthropology
  • Sustainability Science

Articles by Topic

  • Economic Sciences
  • Environmental Sciences
  • Political Sciences
  • Psychological and Cognitive Sciences
  • Social Sciences

Biological Sciences

Featured Portals

  • Sustainability Science

Articles by Topic

  • Agricultural Sciences
  • Anthropology
  • Applied Biological Sciences
  • Biochemistry
  • Biophysics and Computational Biology
  • Cell Biology
  • Developmental Biology
  • Ecology
  • Environmental Sciences
  • Evolution
  • Genetics
  • Immunology and Inflammation
  • Medical Sciences
  • Microbiology
  • Neuroscience
  • Pharmacology
  • Physiology
  • Plant Biology
  • Population Biology
  • Psychological and Cognitive Sciences
  • Sustainability Science
  • Systems Biology
Research Article

Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS–SOS1 interaction

Roman C. Hillig, Brice Sautier, Jens Schroeder, Dieter Moosmayer, André Hilpmann, Christian M. Stegmann, Nicolas D. Werbeck, Hans Briem, Ulf Boemer, Joerg Weiske, Volker Badock, Julia Mastouri, Kirstin Petersen, Gerhard Siemeister, Jan D. Kahmann, Dennis Wegener, Niels Böhnke, Knut Eis, Keith Graham, Lars Wortmann, Franz von Nussbaum, and Benjamin Bader
PNAS February 12, 2019 116 (7) 2551-2560; first published January 25, 2019; https://doi.org/10.1073/pnas.1812963116
Roman C. Hillig
aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: roman.hillig@bayer.com benjamin.bader@bayer.com
Brice Sautier
aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jens Schroeder
aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dieter Moosmayer
aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
André Hilpmann
aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian M. Stegmann
aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas D. Werbeck
aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans Briem
aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulf Boemer
aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joerg Weiske
aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Volker Badock
aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Mastouri
aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kirstin Petersen
aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerhard Siemeister
aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan D. Kahmann
bDrug Discovery Services, Evotec AG, 22419 Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis Wegener
bDrug Discovery Services, Evotec AG, 22419 Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niels Böhnke
aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Knut Eis
aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keith Graham
aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lars Wortmann
aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Franz von Nussbaum
aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Bader
aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: roman.hillig@bayer.com benjamin.bader@bayer.com
  1. Edited by Mariano Barbacid, Spanish National Cancer Research Centre, Madrid, Spain, and approved December 24, 2018 (received for review July 27, 2018)

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF
Loading

Online Impact

 

Article Information

vol. 116 no. 7 2551-2560
DOI: 
https://doi.org/10.1073/pnas.1812963116
PubMed: 
30683722

Published By: 
National Academy of Sciences
Print ISSN: 
0027-8424
Online ISSN: 
1091-6490
History: 
  • Published in issue February 12, 2019.
  • Published first January 25, 2019.

Article Versions

  • Previous version (January 25, 2019 - 09:42).
  • You are viewing the most recent version of this article.
Copyright & Usage: 
Copyright © 2019 the Author(s). Published by PNAS. This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).

Author Information

  1. Roman C. Hilliga,1,
  2. Brice Sautiera,2,
  3. Jens Schroedera,
  4. Dieter Moosmayera,
  5. André Hilpmanna,
  6. Christian M. Stegmanna,
  7. Nicolas D. Werbecka,
  8. Hans Briema,
  9. Ulf Boemera,
  10. Joerg Weiskea,
  11. Volker Badocka,
  12. Julia Mastouria,
  13. Kirstin Petersena,
  14. Gerhard Siemeistera,
  15. Jan D. Kahmannb,
  16. Dennis Wegenerb,
  17. Niels Böhnkea,
  18. Knut Eisa,
  19. Keith Grahama,
  20. Lars Wortmanna,
  21. Franz von Nussbauma, and
  22. Benjamin Badera,1
  1. aResearch and Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany;
  2. bDrug Discovery Services, Evotec AG, 22419 Hamburg, Germany
  1. Edited by Mariano Barbacid, Spanish National Cancer Research Centre, Madrid, Spain, and approved December 24, 2018 (received for review July 27, 2018)

Footnotes

  • ↵1To whom correspondence may be addressed. Email: roman.hillig{at}bayer.com or benjamin.bader{at}bayer.com.
  • ↵2Present address: Medicinal and Synthetic Chemistry, Evotec SAS, 31036 Toulouse Cedex, France.

  • Author contributions: R.C.H., B.S., J.S., D.M., A.H., C.M.S., N.D.W., H.B., K.P., G.S., J.D.K., D.W., N.B., K.E., K.G., L.W., F.v.N., and B.B. designed research; R.C.H., B.S., A.H., H.B., J.M., J.D.K., and D.W. performed research; R.C.H., B.S., J.S., D.M., A.H., C.M.S., N.D.W., H.B., U.B., J.W., V.B., J.M., K.P., G.S., J.D.K., D.W., N.B., K.E., K.G., L.W., and B.B. analyzed data; and R.C.H., B.S., J.S., L.W., and B.B. wrote the paper.

  • Conflict of interest statement: R.C.H. B.S., J.S., D.M., A.H., C.M.S., N.D.W., H.B., U.B., J.W., V.B., J.M., K.P., G.S., N.B., K.E., K.G., L.W., F.v.N., and B.B. are or have been employees and stockholders of Bayer AG. J.D.K. and D.W. are employees of Evotec AG. R.C.H., B.S., J.S., D.M., H.B., K.P., N.B., K.E., L.W., F.v.N., and B.B. are coauthors of a patent application.

  • This article is a PNAS Direct Submission.

  • Data deposition: The atomic coordinates and structure factors have been deposited in the Protein Data Bank, www.wwpdb.org [PDB ID codes 5OVD, 5OVE, 5OVF, 5OVG, 5OVH, and 5OVI (SOS1 complexes); 6EIE (SOS2); and 6EPL, 6EPM, 6EPN, 6EPO, and 6EPP (KRAS–SOS1 complexes)].

  • This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1812963116/-/DCSupplemental.

Cited By...

  • 42 Citations
  • 55 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne?
    Misako Nagasaka, Yiwei Li, Ammar Sukari, Sai-Hong Ignatius Ou, Mohammed Najeeb Al-Hallak, Asfar S. Azmi
    Cancer Treatment Reviews 2020 84
  • RAS-targeted therapies: is the undruggable drugged?
    Amanda R. Moore, Scott C. Rosenberg, Frank McCormick, Shiva Malek
    Nature Reviews Drug Discovery 2020 19 8
  • Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
    Michael A. Gillette, Shankha Satpathy, Song Cao, Saravana M. Dhanasekaran, Suhas V. Vasaikar, Karsten Krug, Francesca Petralia, Yize Li, Wen-Wei Liang, Boris Reva, Azra Krek, Jiayi Ji, Xiaoyu Song, Wenke Liu, Runyu Hong, Lijun Yao, Lili Blumenberg, Sara R. Savage, Michael C. Wendl, Bo Wen, Kai Li, Lauren C. Tang, Melanie A. MacMullan, Shayan C. Avanessian, M. Harry Kane, Chelsea J. Newton, MacIntosh Cornwell, Ramani B. Kothadia, Weiping Ma, Seungyeul Yoo, Rahul Mannan, Pankaj Vats, Chandan Kumar-Sinha, Emily A. Kawaler, Tatiana Omelchenko, Antonio Colaprico, Yifat Geffen, Yosef E. Maruvka, Felipe da Veiga Leprevost, Maciej Wiznerowicz, Zeynep H. Gümüş, Rajwanth R. Veluswamy, Galen Hostetter, David I. Heiman, Matthew A. Wyczalkowski, Tara Hiltke, Mehdi Mesri, Christopher R. Kinsinger, Emily S. Boja, Gilbert S. Omenn, Arul M. Chinnaiyan, Henry Rodriguez, Qing Kay Li, Scott D. Jewell, Mathangi Thiagarajan, Gad Getz, Bing Zhang, David Fenyö, Kelly V. Ruggles, Marcin P. Cieslik, Ana I. Robles, Karl R. Clauser, Ramaswamy Govindan, Pei Wang, Alexey I. Nesvizhskii, Li Ding, D.R. Mani, Steven A. Carr, Alex Webster, Alicia Francis, Alyssa Charamut, Amanda G. Paulovich, Amy M. Perou, Andrew K. Godwin, Andrii Karnuta, Annette Marrero-Oliveras, Barbara Hindenach, Barbara Pruetz, Bartosz Kubisa, Brian J. Druker, Chet Birger, Corbin D. Jones, Dana R. Valley, Daniel C. Rohrer, Daniel Cui Zhou, Daniel W. Chan, David Chesla, David J. Clark, Dmitry Rykunov, Donghui Tan, Elena V. Ponomareva, Elizabeth Duffy, Eric J. Burks, Eric E. Schadt, Erik J. Bergstrom, Eugene S. Fedorov, Ewa Malc, George D. Wilson, Hai-Quan Chen, Halina M. Krzystek, Hongwei Liu, Houston Culpepper, Hua Sun, Hui Zhang, Jacob Day, James Suh, Jeffrey R. Whiteaker, Jennifer Eschbacher, John McGee, Karen A. Ketchum, Karin D. Rodland, Karna Robinson, Katherine A. Hoadley, Kei Suzuki, Ki Sung Um, Kim Elburn, Liang-Bo Wang, Lijun Chen, Linda Hannick, Liqun Qi, Lori J. Sokoll, Małgorzata Wojtyś, Marcin J. Domagalski, Marina A. Gritsenko, Mary B. Beasley, Matthew E. Monroe, Matthew J. Ellis, Maureen Dyer, Meghan C. Burke, Melissa Borucki, Meng-Hong Sun, Michael H. Roehrl, Michael J. Birrer, Michael Noble, Michael Schnaubelt, Michael Vernon, Michelle Chaikin, Mikhail Krotevich, Munziba Khan, Myvizhi Esai Selvan, Nancy Roche, Nathan J. Edwards, Negin Vatanian, Olga Potapova, Pamela Grady, Peter B. McGarvey, Piotr Mieczkowski, Pushpa Hariharan, Rashna Madan, Ratna R. Thangudu, Richard D. Smith, Robert J. Welsh, Robert Zelt, Rohit Mehra, Ronald Matteotti, Sailaja Mareedu, Samuel H. Payne, Sandra Cottingham, Sanford P. Markey, Seema Chugh, Shaleigh Smith, Shirley Tsang, Shuang Cai, Simina M. Boca, Sonya Carter, Stacey Gabriel, Stephanie De Young, Stephen E. Stein, Sunita Shankar, Tanya Krubit, Tao Liu, Tara Skelly, Thomas Bauer, Uma Velvulou, Umut Ozbek, Vladislav A. Petyuk, Volodymyr Sovenko, William E. Bocik, William W. Maggio, Xi Chen, Yan Shi, Yige Wu, Yingwei Hu, Yuxing Liao, Zhen Zhang, Zhiao Shi
    Cell 2020 182 1
  • The current understanding of KRAS protein structure and dynamics
    Tatu Pantsar
    Computational and Structural Biotechnology Journal 2020 18
  • Targeting the Small GTPase Superfamily through Their Regulatory Proteins
    Janine L. Gray, Frank Delft, Paul E. Brennan
    Angewandte Chemie International Edition 2020 59 16
  • Targeting the MAPK Pathway in KRAS-Driven Tumors
    Matthias Drosten, Mariano Barbacid
    Cancer Cell 2020 37 4
  • RAS, wanted dead or alive: Advances in targeting RAS mutant cancers
    Clint A. Stalnecker, Channing J. Der
    Science Signaling 2020 13 624
  • Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C
    Jason G. Kettle, Sharan K. Bagal, Sue Bickerton, Michael S. Bodnarchuk, Jason Breed, Rodrigo J. Carbajo, Doyle J. Cassar, Atanu Chakraborty, Sabina Cosulich, Iain Cumming, Michael Davies, Andrew Eatherton, Laura Evans, Lyman Feron, Shaun Fillery, Emma S. Gleave, Frederick W. Goldberg, Stephanie Harlfinger, Lyndsey Hanson, Martin Howard, Rachel Howells, Anne Jackson, Paul Kemmitt, Jennifer K. Kingston, Scott Lamont, Hilary J. Lewis, Songlei Li, Libin Liu, Derek Ogg, Christopher Phillips, Radek Polanski, Graeme Robb, David Robinson, Sarah Ross, James M. Smith, Michael Tonge, Rebecca Whiteley, Junsheng Yang, Longfei Zhang, Xiliang Zhao
    Journal of Medicinal Chemistry 2020 63 9
  • Advancing RAS/RASopathy therapies: An NCI‐sponsored intramural and extramural collaboration for the study of RASopathies
    Andrea M. Gross, Megan Frone, Karen W. Gripp, Bruce D. Gelb, Lisa Schoyer, Lisa Schill, Beth Stronach, Leslie G. Biesecker, Dominic Esposito, Edjay Ralph Hernandez, Eric Legius, Mignon L. Loh, Staci Martin, Deborah K. Morrison, Katherine A. Rauen, Pamela L. Wolters, Dina Zand, Frank McCormick, Sharon A. Savage, Douglas R. Stewart, Brigitte C. Widemann, Marielle E. Yohe
    American Journal of Medical Genetics Part A 2020 182 4
  • BI-3406, a Potent and Selective SOS1–KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition
    Marco H. Hofmann, Michael Gmachl, Juergen Ramharter, Fabio Savarese, Daniel Gerlach, Joseph R. Marszalek, Michael P. Sanderson, Dirk Kessler, Francesca Trapani, Heribert Arnhof, Klaus Rumpel, Dana-Adriana Botesteanu, Peter Ettmayer, Thomas Gerstberger, Christiane Kofink, Tobias Wunberg, Andreas Zoephel, Szu-Chin Fu, Jessica L. Teh, Jark Böttcher, Nikolai Pototschnig, Franziska Schachinger, Katharina Schipany, Simone Lieb, Christopher P. Vellano, Jonathan C. O'Connell, Rachel L. Mendes, Jurgen Moll, Mark Petronczki, Timothy P. Heffernan, Mark Pearson, Darryl B. McConnell, Norbert Kraut
    Cancer Discovery 2021 11 1
  • PDE6D Inhibitors with a New Design Principle Selectively Block K-Ras Activity
    Farid A. Siddiqui, Catharina Alam, Petja Rosenqvist, Mikko Ora, Ahmed Sabt, Ganesh babu Manoharan, Lakshman Bindu, Sunday Okutachi, Marie Catillon, Troy Taylor, Omaima M. Abdelhafez, Harri Lönnberg, Andrew G. Stephen, Anastassios C. Papageorgiou, Pasi Virta, Daniel Abankwa
    ACS Omega 2020 5 1
  • Phosphoproteomic quantitation and causal analysis reveal pathways in GPVI/ITAM-mediated platelet activation programs
    Özgün Babur, Alexander R. Melrose, Jennifer M. Cunliffe, John Klimek, Jiaqing Pang, Anna-Liisa I. Sepp, Jevgenia Zilberman-Rudenko, Samuel Tassi Yunga, Tony Zheng, Iván Parra-Izquierdo, Jessica Minnier, Owen J. T. McCarty, Emek Demir, Ashok P. Reddy, Phillip A. Wilmarth, Larry L. David, Joseph E. Aslan
    Blood 2020 136 20
  • Structural Insights into the Regulation Mechanism of Small GTPases by GEFs
    Toma-Fukai, Shimizu
    Molecules 2019 24 18
  • Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers
    Tyler E. Mattox, Xi Chen, Yulia Y. Maxuitenko, Adam B. Keeton, Gary A. Piazza
    International Journal of Molecular Sciences 2019 21 1
  • Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR
    Hengyu Lu, Chen Liu, Hung Huynh, Thi Bich Uyen Le, Matthew J. LaMarche, Morvarid Mohseni, Jeffrey A. Engelman, Peter S. Hammerman, Giordano Caponigro, Huai-Xiang Hao
    Oncotarget 2020 11 3
  • Current Approaches in NSCLC Targeting K-RAS and EGFR
    Veronica Aran, Jasminka Omerovic
    International Journal of Molecular Sciences 2019 20 22
  • Current therapy of KRAS-mutant lung cancer
    Aron Ghimessy, Peter Radeczky, Viktoria Laszlo, Balazs Hegedus, Ferenc Renyi-Vamos, Janos Fillinger, Walter Klepetko, Christian Lang, Balazs Dome, Zsolt Megyesfalvi
    Cancer and Metastasis Reviews 2020 39 4
  • Mutant-Specific Targeting of Ras G12C Activity by Covalently Reacting Small Molecules
    Roger S. Goody, Matthias P. Müller, Daniel Rauh
    Cell Chemical Biology 2019 26 10
  • Targeting KRAS(G12C): From Inhibitory Mechanism to Modulation of Antitumor Effects in Patients
    Dongsung Kim, Jenny Yaohua Xue, Piro Lito
    Cell 2020 183 4
  • The Ras switch in structural and historical perspective
    Raphael Gasper, Fred Wittinghofer
    Biological Chemistry 2019 401 1
  • KRAS: A Promising Therapeutic Target for Cancer Treatment
    Hai-Zhou Wu, Jia-Qi Xiao, Song-Shu Xiao, Yan Cheng
    Current Topics in Medicinal Chemistry 2019 19 23
  • J. Matthew Rhett, Imran Khan, John P. O’Bryan
    2020 148
  • Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor
    Julien Lefranc, Volker Klaus Schulze, Roman Christian Hillig, Hans Briem, Florian Prinz, Anne Mengel, Tobias Heinrich, Jozsef Balint, Srinivasan Rengachari, Horst Irlbacher, Detlef Stöckigt, Ulf Bömer, Benjamin Bader, Stefan Nikolaus Gradl, Carl Friedrich Nising, Franz von Nussbaum, Dominik Mumberg, Daniel Panne, Antje Margret Wengner
    Journal of Medicinal Chemistry 2020 63 2
  • Dissociation of the Signaling Protein K‐Ras4B from Lipid Membranes Induced by a Molecular Tweezer
    Lei Li, Nelli Erwin, Simone Möbitz, Felix Niemeyer, Thomas Schrader, Roland Hermann Alfons Winter
    Chemistry – A European Journal 2019 25 42
  • Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs
    Vijay Kumar Bhardwaj, Rahul Singh, Pralay Das, Rituraj Purohit
    Computers in Biology and Medicine 2021 128
  • KRAS(G12C)–AMG 510 interaction dynamics revealed by all-atom molecular dynamics simulations
    Tatu Pantsar
    Scientific Reports 2020 10 1
  • NMR in integrated biophysical drug discovery for RAS: past, present, and future
    Christopher B. Marshall, Fenneke KleinJan, Teklab Gebregiworgis, Ki-Young Lee, Zhenhao Fang, Ben J. Eves, Ningdi F. Liu, Geneviève M. C. Gasmi-Seabrook, Masahiro Enomoto, Mitsuhiko Ikura
    Journal of Biomolecular NMR 2020 74 10-11
  • Overcoming Resistance to Drugs Targeting KRAS Mutation
    Delong Jiao, Shengyu Yang
    The Innovation 2020 1 2
  • Structural impact of GTP binding on downstream KRAS signaling
    Dóra K. Menyhárd, Gyula Pálfy, Zoltán Orgován, István Vida, György M. Keserű, András Perczel
    Chemical Science 2020 11 34
  • Computationally Empowered Workflow Identifies Novel Covalent Allosteric Binders for KRAS G12C
    Jérémie Mortier, Anders Friberg, Volker Badock, Dieter Moosmayer, Jens Schroeder, Patrick Steigemann, Franziska Siegel, Stefan Gradl, Marcus Bauser, Roman C. Hillig, Hans Briem, Knut Eis, Benjamin Bader, Duy Nguyen, Clara D. Christ
    ChemMedChem 2020 15 10
  • Application of Fragment-Based Drug Discovery to Versatile Targets
    Qingxin Li
    Frontiers in Molecular Biosciences 2020 7
  • Discovery of Sulfonamide-Derived Agonists of SOS1-Mediated Nucleotide Exchange on RAS Using Fragment-Based Methods
    Dhruba Sarkar, Edward T. Olejniczak, Jason Phan, Jesse A. Coker, Jiqing Sai, Allison Arnold, Yugandhar Beesetty, Alex G. Waterson, Stephen W. Fesik
    Journal of Medicinal Chemistry 2020 63 15
  • Inhibition of K-Ras4B-plasma membrane association with a membrane microdomain-targeting peptide
    Fang-Yi Li, Zhen-Feng Zhang, Stephanie Voss, Yao-Wen Wu, Yu-Fen Zhao, Yan-Mei Li, Yong-Xiang Chen
    Chemical Science 2020 11 3
  • Marked synergy by vertical inhibition of EGFR signaling in NSCLC spheroids shows SOS1 is a therapeutic target in EGFR-mutated cancer
    Patricia L Theard, Erin Sheffels, Nancy E Sealover, Amanda J Linke, David J Pratico, Robert L Kortum
    eLife 2020 9
  • Selective apoptosis-inducing activity of synthetic hydrocarbon-stapled SOS1 helix with d-amino acids in H358 cancer cells expressing KRASG12C
    Li-li Xu, Cui-cui Li, Lu-yan An, Zhen Dai, Xiao-yi Chen, Qi-dong You, Chi Hu, Bin Di
    European Journal of Medicinal Chemistry 2020 185
  • Small molecule inhibitors of RAS proteins with oncogenic mutations
    Zoltán Orgován, György M. Keserű
    Cancer and Metastasis Reviews 2020 39 4
  • Structure-based inhibitor design of mutant RAS proteins—a paradigm shift
    Kinga Nyíri, Gergely Koppány, Beáta G. Vértessy
    Cancer and Metastasis Reviews 2020 39 4
  • Targeting RAS in pediatric cancer
    Angelina V. Vaseva, Marielle E. Yohe
    Current Opinion in Pediatrics 2020 32 1
  • Ubiquitin-specific peptide 22 acts as an oncogene in gastric cancer in a son of sevenless 1-dependent manner
    ChitChoon Lim, Jia-Cheng Xu, Tian-Yin Chen, Jia-Xin Xu, Wei-Feng Chen, Jian-Wei Hu, Quan-Lin Li, Yi-Qun Zhang
    Cancer Cell International 2020 20 1
  • Beyond the Genomic Mutation: Rethinking the Molecular Biomarkers of K-RAS Dependency in Pancreatic Cancers
    Carla Mottini, Luca Cardone
    International Journal of Molecular Sciences 2020 21 14
  • Crystal structure of the SH3 domain of growth factor receptor-bound protein 2
    Alexandr Bolgov, Svetlana Korban, Dmitrii Luzik, Vladimir Zhemkov, Meewhi Kim, Olga Rogacheva, Ilya Bezprozvanny
    Acta Crystallographica Section F Structural Biology Communications 2020 76 6
  • Fragment-to-Lead Medicinal Chemistry Publications in 2019
    Wolfgang Jahnke, Daniel A. Erlanson, Iwan J. P. de Esch, Christopher N. Johnson, Paul N. Mortenson, Yuji Ochi, Tatsuya Urushima
    Journal of Medicinal Chemistry 2020 63 24
  • Generation of KS-58 as the first K-Ras(G12D)-inhibitory peptide presenting anti-cancer activity in vivo
    Kotaro Sakamoto, Teruaki Masutani, Takatsugu Hirokawa
    Scientific Reports 2020 10 1
  • In silico and saturation transfer difference NMR approaches to unravel the binding mode of an andrographolide derivative to K-Ras oncoprotein
    Shun Ying Quah, Michelle Siying Tan, Kok Lian Ho, Nizar Abdul Manan, Alemayehu Abebe Gorfe, Pran Kishore Deb, Sreenivasa Rao Sagineedu, Johnson Stanslas
    Future Medicinal Chemistry 2020 12 18
  • Inhibition of RAF dimers: it takes two to tango
    Frazer A. Cook, Simon J. Cook
    Biochemical Society Transactions 2020
  • KRASG12C inhibitor: combing for combination
    Atanu Chakraborty
    Biochemical Society Transactions 2020 48 6
  • Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development
    Outi M. H. Salo-Ahen, Ida Alanko, Rajendra Bhadane, Alexandre M. J. J. Bonvin, Rodrigo Vargas Honorato, Shakhawath Hossain, André H. Juffer, Aleksei Kabedev, Maija Lahtela-Kakkonen, Anders Støttrup Larsen, Eveline Lescrinier, Parthiban Marimuthu, Muhammad Usman Mirza, Ghulam Mustafa, Ariane Nunes-Alves, Tatu Pantsar, Atefeh Saadabadi, Kalaimathy Singaravelu, Michiel Vanmeert
    Processes 2020 9 1
  • Natural Products Attenuating Biosynthesis, Processing, and Activity of Ras Oncoproteins: State of the Art and Future Perspectives
    Renata Tisi, Vadim Gaponenko, Marco Vanoni, Elena Sacco
    Biomolecules 2020 10 11
  • Post-translational modification of KRAS: potential targets for cancer therapy
    Wei-hua Wang, Tao Yuan, Mei-jia Qian, Fang-jie Yan, Liu Yang, Qiao-jun He, Bo Yang, Jin-jian Lu, Hong Zhu
    Acta Pharmacologica Sinica 2020
  • Reference Module in Biomedical Sciences
    Walter V. Velasco, Marco Ramos-Castaneda, Michael J. Clowers, Shanshan Deng, Seyed Javad Moghaddam
    2020
  • SOS GEFs in health and disease
    Fernando C. Baltanás, Natasha Zarich, Jose M. Rojas-Cabañeros, Eugenio Santos
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020 1874 2
  • Suppressing Nucleotide Exchange to Inhibit KRAS-Mutant Tumors
    Yulei Zhao, Jenny Y. Xue, Piro Lito
    Cancer Discovery 2021 11 1
  • Targeting KRAS mutant cancers by preventing signaling transduction in the MAPK pathway
    Claudia Korzeniecki, Ronny Priefer
    European Journal of Medicinal Chemistry 2020
  • Targeting KRAS-Mutant Non–Small-Cell Lung Cancer: One Mutation at a Time, With a Focus on KRAS G12C Mutations
    Timothy F. Burns, Hossein Borghaei, Suresh S. Ramalingam, Tony S. Mok, Solange Peters
    Journal of Clinical Oncology 2020 38 35
  • Targeting der kleinen GTPasen über ihre regulatorischen Proteine
    Janine L. Gray, Frank Delft, Paul E. Brennan
    Angewandte Chemie 2020 132 16

Article usage

Article usage: January 2019 to January 2021

AbstractFullPdf
Jan 201935019791182
Feb 201921012050861
Mar 20193261050381
Apr 2019218788250
May 2019190494189
Jun 2019250576207
Jul 2019481534189
Aug 2019837715192
Sep 2019737764233
Oct 20197831651568
Nov 20195441633553
Dec 2019363922312
Total 20197180131565117
Jan 2020126911308
Feb 202091970341
Mar 202080814292
Apr 2020361091430
May 202063978443
Jun 202025774290
Jul 202026773284
Aug 202024820256
Sep 202027963307
Oct 2020125875281
Nov 202081823294
Dec 202089750260
Total 2020793105423786
Jan 202131477131
Total 202131477131
Total8004241759034
PreviousNext
Back to top
Article Alerts
Email Article

Thank you for your interest in spreading the word on PNAS.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS–SOS1 interaction
(Your Name) has sent you a message from PNAS
(Your Name) thought you would like to see the PNAS web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS–SOS1 interaction
Roman C. Hillig, Brice Sautier, Jens Schroeder, Dieter Moosmayer, André Hilpmann, Christian M. Stegmann, Nicolas D. Werbeck, Hans Briem, Ulf Boemer, Joerg Weiske, Volker Badock, Julia Mastouri, Kirstin Petersen, Gerhard Siemeister, Jan D. Kahmann, Dennis Wegener, Niels Böhnke, Knut Eis, Keith Graham, Lars Wortmann, Franz von Nussbaum, Benjamin Bader
Proceedings of the National Academy of Sciences Feb 2019, 116 (7) 2551-2560; DOI: 10.1073/pnas.1812963116

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS–SOS1 interaction
Roman C. Hillig, Brice Sautier, Jens Schroeder, Dieter Moosmayer, André Hilpmann, Christian M. Stegmann, Nicolas D. Werbeck, Hans Briem, Ulf Boemer, Joerg Weiske, Volker Badock, Julia Mastouri, Kirstin Petersen, Gerhard Siemeister, Jan D. Kahmann, Dennis Wegener, Niels Böhnke, Knut Eis, Keith Graham, Lars Wortmann, Franz von Nussbaum, Benjamin Bader
Proceedings of the National Academy of Sciences Feb 2019, 116 (7) 2551-2560; DOI: 10.1073/pnas.1812963116
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Mendeley logo Mendeley
Proceedings of the National Academy of Sciences: 116 (7)
Table of Contents

Submit

Sign up for Article Alerts

Article Classifications

  • Biological Sciences
  • Biochemistry

Jump to section

  • Article
    • Abstract
    • Results
    • Discussion
    • Materials and Methods
    • Acknowledgments
    • Footnotes
    • References
  • Figures & SI
  • Info & Metrics
  • PDF

You May Also be Interested in

Abstract depiction of a guitar and musical note
Science & Culture: At the nexus of music and medicine, some see disease treatments
Although the evidence is still limited, a growing body of research suggests music may have beneficial effects for diseases such as Parkinson’s.
Image credit: Shutterstock/agsandrew.
Scientist looking at an electronic tablet
Opinion: Standardizing gene product nomenclature—a call to action
Biomedical communities and journals need to standardize nomenclature of gene products to enhance accuracy in scientific and public communication.
Image credit: Shutterstock/greenbutterfly.
One red and one yellow modeled protein structures
Journal Club: Study reveals evolutionary origins of fold-switching protein
Shapeshifting designs could have wide-ranging pharmaceutical and biomedical applications in coming years.
Image credit: Acacia Dishman/Medical College of Wisconsin.
White and blue bird
Hazards of ozone pollution to birds
Amanda Rodewald, Ivan Rudik, and Catherine Kling talk about the hazards of ozone pollution to birds.
Listen
Past PodcastsSubscribe
Goats standing in a pin
Transplantation of sperm-producing stem cells
CRISPR-Cas9 gene editing can improve the effectiveness of spermatogonial stem cell transplantation in mice and livestock, a study finds.
Image credit: Jon M. Oatley.

Similar Articles

Site Logo
Powered by HighWire
  • Submit Manuscript
  • Twitter
  • Facebook
  • RSS Feeds
  • Email Alerts

Articles

  • Current Issue
  • Latest Articles
  • Archive

PNAS Portals

  • Anthropology
  • Chemistry
  • Classics
  • Front Matter
  • Physics
  • Sustainability Science
  • Teaching Resources

Information

  • Authors
  • Editorial Board
  • Reviewers
  • Librarians
  • Press
  • Site Map
  • PNAS Updates

Feedback    Privacy/Legal

Copyright © 2021 National Academy of Sciences. Online ISSN 1091-6490